Home › Funds › Casdin Capital › TNYA

Casdin Capital position in TNYA

TENAYA THERAPEUTICS INC · Health Care

Casdin Capital reported holding 361,969 shares of TNYA (TENAYA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$268K, representing 0.01% of its reported portfolio and ranking #43 among its reported holdings. Casdin Capital has disclosed TNYA holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

Latest position (Q2 2026)361.97K sh
Reported value held$267.53K
Portfolio Weight0.01%
First reportedQ3 2021
Last changeHold
Updated2026-10-05

Last updated: 2026-10-05 · Source: SEC EDGAR Form 13F-HR

How Casdin Capital's TNYA position evolved

Casdin Capital first disclosed a stake in TNYA in Q3 2021 at 3,586,818 shares (US$74.1M). Across 20 filings, Casdin Capital increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 15 time(s). The most recent filing (Q2 2026) shows 361,969 shares valued at US$268K. Notable position changes include a 69% increase in Q4 2022 (shares rose 42% over the following quarter), a 95% trim in Q2 2025 (shares rose 165% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 3.59M $74.07M New
Q4 2021 3.59M $67.97M Hold
Q1 2022 3.59M $42.25M Hold
Q2 2022 3.59M $20.19M Hold
Q3 2022 3.59M $10.40M Hold
Q4 2022 6.08M $12.22M Add
Q1 2023 6.08M $17.32M Hold
Q2 2023 6.38M $37.46M Add
Q3 2023 6.38M $16.27M Hold
Q4 2023 6.38M $20.68M Hold
Q1 2024 6.73M $35.21M Add
Q2 2024 6.73M $20.87M Hold
Q3 2024 6.73M $12.99M Hold
Q4 2024 6.73M $9.63M Hold
Q1 2025 6.73M $3.84M Hold
Q2 2025 361.97K $221.24K Reduce
Q3 2025 361.97K $586.39K Hold
Q4 2025 361.97K $257.54K Hold
Q1 2026 361.97K $250.63K Hold
Q2 2026 361.97K $267.53K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNYA and 13F data

TNYA (TENAYA THERAPEUTICS INC) is a Health Care company. 20 other funds we track also report a position in TNYA — the largest reported positions include Empery Asset Management, LP (US$2.9M), Euclidean Capital LLC (US$751K), StepStone Group LP (US$342K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNYA

All TNYA fund holders →

FAQ

How long has Casdin Capital held TNYA?

Casdin Capital has disclosed TNYA holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

What is Casdin Capital's current position in TNYA?

As of Q2 2026, Casdin Capital holds 361.97K shares of TNYA (TENAYA THERAPEUTICS INC), valued at $267.53K, representing 0.01% of its reported portfolio and ranking #43.

Has Casdin Capital been buying or selling TNYA?

In the latest 13F filing (Q2 2026), Casdin Capital held unchanged its position in TNYA.

Which other funds hold TNYA?

Other major institutional holders of TNYA include Empery Asset Management, LP, Euclidean Capital LLC, StepStone Group LP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.